Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Eur J Paediatr Dent ; 22(1): 26-30, 2021.
Article in English | MEDLINE | ID: mdl-33719479

ABSTRACT

AIM: The current study aimed to analyse the dentoskeletal effects of the Invisalign mandibular advancement (MA) device in the treatment of skeletal Class II malocclusions. MATERIALS AND METHODS: Pre-treatment and post-treatment lateral skull radiographs from patients treated with MA versus TB (Twin-Block Appliance) at the Department of Orthodontics of the University of L'Aquila, Italy, were traced. Eligibility criteria included SNB<78; ANB>4; no previous orthodontic treatments; and vertebral maturation stage (CVM) CS3. Radiographs from patients with craniofacial anomalies, or who underwent extraction treatments, were excluded. Totally, 20 patients were examined, 10 of whom treated with MA and 10 treated with TB. All the radiographs were traced by one expert operator, blind to the groups. A preliminary method error study was performed to exclude intra-operator differences. RESULTS: Baseline characteristics of the participants were similar between the groups. Both appliances demonstrated a reduction of SNB and ANB angle, and a decrease in overjet. TB demonstrated a higher efficacy in increasing mandibular dimensions. A significant retroinclination of the upper incisive was observed in the TB group, where a decrease of SNA angles was additionally observed. The resulting differences between the two groups could be attributed to the different design of the appliances. CONCLUSIONS: The present data show the effectiveness of both TB and MA in the management of skeletal Class II malocclusions due to mandibular retrusion. But some differences exist in the dentoalveolar effect of the two appliances. MA seems indicated in Class II cases where a control of the upper frontal teeth position is needed.


Subject(s)
Malocclusion, Angle Class II , Mandibular Advancement , Orthodontic Appliances, Functional , Orthodontic Appliances, Removable , Cephalometry , Humans , Italy , Malocclusion, Angle Class II/diagnostic imaging , Malocclusion, Angle Class II/therapy , Mandible , Retrospective Studies , Treatment Outcome
2.
Eur J Paediatr Dent ; 20(2): 116-118, 2019 Jun.
Article in English | MEDLINE | ID: mdl-31246086

ABSTRACT

AIM: The aim of this study is to analyse the correspondence between the reported number of activations and the number of prescribed activations. MATERIALS AND METHODS: A total of 114 subjects with constricted maxillary arches (58 males, 56 females; mean age 10.26 ± 1.92 years) were enrolled in the study. The subjects underwent RME and all the parents were provided with a screw activations report form in order to remind them the number of prescribed activations. At the removal of the expander, the screw was turned back in order to count the effective number of activations applied. RESULTS: In 46 cases, out of a total of 114 patients, an involuntary error during the activation procedure was presumably made. A slight statistically significant correlation between the number of activations prescribed, and the number of incorrect activations was found. The errors consisted in added or missed activations, compared to the prescribed number but more frequently in missed activations with statistical significance. CONCLUSION: Errors in following the rapid palatal expansion activation protocol are not uncommon. These errors could consist in missed or added activations to the number prescribed by the orthodontist, more often in missed ctivations.


Subject(s)
Maxilla , Palatal Expansion Technique , Child , Female , Humans , Male , Palate
3.
Eur J Paediatr Dent ; 19(2): 151-155, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29790780

ABSTRACT

AIM: The aim of this study is to compare the sagittal dentoskeletal changes associated with different activation protocols of maxillary expander. MATERIALS AND METHODS: A total of 101 subjects with constricted maxillary arches (49 males and 52 females; mean age 10.08 ± 1.57 years) were enrolled in the study. The study comprised also a control group of 20 subjects (11 females and 9 males, mean age 10.27 ± 1.24 years) who were not treated during the observation period. All the subjects underwent rapid maxillary expansion with a stainless steel banded expander cemented to the maxillary first molars. The expansion screw was randomly activated with two different rapid maxillary expansion protocols (one-quarter per day or two-quarters per day). A statistical comparison between the sagittal cephalometric variations obtained in the two expansion groups was made, and compared with the untreated control group. Data were then stratified for skeletal maturation of each subject. RESULTS: The Wilcoxon rank-sum test shows statistically significant differences between the two RME activation protocols only for overjet. Statistically significant differences were reported in comparison with the control group. CONCLUSIONS: This study suggests that the increase in overjet after RME could be associated with faster activation protocols especially in subjects with lower skeletal maturation.


Subject(s)
Palatal Expansion Technique , Cephalometry , Child , Female , Humans , Jaw Relation Record , Male , Orthodontic Appliance Design , Treatment Outcome
4.
BMC Pediatr ; 18(1): 136, 2018 04 13.
Article in English | MEDLINE | ID: mdl-29653566

ABSTRACT

BACKGROUND: Minor Recurrent Aphthous Stomatitis (RAS) represents a disease which is very difficult to prevent. This case-control study focused on possible associations between minor Recurrent Aphthous Stomatitis in children, their oral health, and underlying behavioral indexes of children's attitudes and habits pertaining to (home) oral hygiene, with the further goal of enabling the dentist to prevent these specific kind of lesions, both from a clinical and a broader psychosocial perspective. METHODS: Four hundred one school-children (5-10 years old) in Milan (Italy) were submitted to an intra-oral examination, and interviewed with the aid of a brief psychosocial questionnaire. RESULTS: At the clinical level, statistically significant associations were observed between the presence of decayed teeth and minor Recurrent Aphthous Stomatitis (Odds Ratio: 3.15; 95% CI: lower limit 1.06; upper limit: 9.36; Z-test: 2.07, p = 0.039; Chi-square = 4.71, p = 0.030), and between the Decayed Missing or Filled Teeth (DMFT) index and minor aphthous stomatitis (Odds Ratio: 3.30; 95% CI: lower limit 1.13; upper limit: 9.67; Z-test = 2.18, p = 0.029; Chi-square = 5.27; p = 0.022), both results pointing to a significant increase-by circa 3 times-in the risk of developing minor Recurrent Aphthous Stomatitis in children exposed to the two above-identified factors (i.e., the presence of decayed teeth and a clearly compromised oral condition, as signaled by the DMFT index), if compared with the risk run by their non-exposed counterparts. At the psychosocial level of analysis, statistically significant associations were observed (1) between children's practice of spontaneously brushing teeth when not at home and a comparatively lower (i.e. better) Decayed Missing or Filled Teeth index (Chi-square: 8.95; p = 0.011), and (2) between receiving parental aid (e.g., proper brushing instructions) while practicing home oral hygiene and a significantly reduced presence of decayed teeth (Chi-square = 5.40; p = .067; Spearman's Rho, p = .038). Further, significant associations were also observed between children's reported severity of dental pain and both (a) the presence of decayed teeth (Chi-square = 10.80; p = 0.011), and (b) children's (poor) oral health condition as expressed by the Decayed Missing or Filled Teeth index (Chi-square = 6.29; p = 0.043). Interestingly, specific lifestyles and social status, showed no systematic association to other clinical or psychological/psychosocial indices. CONCLUSIONS: These systematic relations suggest that, in the presence of Recurrent Aphthous Stomatitis in pediatric patients, the dentist should carefully monitor children for potential carious lesions, implement protocols of prevention to control Recurrent Aphthous Stomatitis disease in children affected by caries, and also be particularly aware of the right or wrong habits children may acquire in the course of continued social exchange with their caregivers and peers.


Subject(s)
Attitude to Health , Habits , Oral Hygiene/psychology , Stomatitis, Aphthous/epidemiology , Case-Control Studies , Child , Child, Preschool , Dental Caries/complications , Dental Caries/epidemiology , Dental Caries/prevention & control , Female , Humans , Italy/epidemiology , Male , Recurrence , Stomatitis, Aphthous/complications , Stomatitis, Aphthous/prevention & control , Stomatitis, Aphthous/psychology , Surveys and Questionnaires
5.
Eur J Paediatr Dent ; 19(1): 35-39, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29569451

ABSTRACT

AIM: The aim of this study is to compare dental arch changes associated with different activation protocols of maxillary expander. MATERIALS AND METHODS: A sample of 101 subjects with constricted maxillary arches (49 males and 52 females; mean age 10.96 ± 1.91 years) was enrolled in the study. All subjects underwent RME with a stainless steel banded expander cemented to the maxillary first molars and the expansion screw was randomly activated with two different rapid maxillary expansion protocols (one- quarter per day or two quarters per day). The study also involved a control group of 22 subjects (10 females and 12 males, mean age 10.39 ± 1.32 years) who underwent no treatment. A statistical comparison between the dental arch measures obtained before and after treatment in the two groups was performed. RESULTS: The Wilcoxon rank-sum test shows statistically significant differences of the measurement increases between the two activation protocols (at least p=0.01). Statistically significant differences were also reported in comparison with the control group. CONCLUSIONS: A faster activation protocol could be able to determine a greater anterior opening of the mid-palatal suture. Moreover, it seems to yield a higher width increase in the molar area.


Subject(s)
Dental Arch/anatomy & histology , Palatal Expansion Technique , Case-Control Studies , Child , Female , Humans , Jaw Relation Record , Male
6.
Malawi Med J ; 27(1): 25-8, 2015 Mar.
Article in English | MEDLINE | ID: mdl-26137195

ABSTRACT

BACKGROUND: Defaulting scheduled rehabilitation therapy may result in increased adverse outcomes such as permanent disability and increased healthcare costs. Concomitantly, there is evidence to suggest that early and continued rehabilitation of children with congenital disabilities can improve outcomes significantly. This study was conducted to determine factors contributing to caregivers' defaulting scheduled rehabilitation therapy sessions. METHODS: A descriptive cross sectional study was carried out at Chitungwiza Central Hospital, a tertiary facility offering in and outpatient rehabilitation services in Zimbabwe. Caregivers of children who had congenital disabilities (N=40) and who had a history of defaulting treatment but were available during the data collection period responded to an interviewer administered questionnaire. Data were analysed for means and frequencies using STATA 13. RESULTS: Factors that contributed to caregivers defaulting scheduled therapy included economic constraints (52%), child related factors (43%), caregiver related factors (42%), service centred factors (30%) and psychosocial factors(58%). Majority of the caregivers (98%) were motivated to attend therapy by observable improvements in their children. Other motivators were incentives given in the rehabilitation department (45%), availability of rehabilitation personnel to provide the required services (48%) and psychosocial support from fellow caregivers, families and the rehabilitation staff (68%). Although all the caregivers could not distinguish occupational therapy from physiotherapy services they all reported that therapy was important. CONCLUSIONS: A combination of psychosocial, economic, child centred and service centred factors contributed to caregivers defaulting scheduled therapy. Interventions that may potentially improve caregiver attendance to scheduled therapy include community outreach services, efficient rehabilitation service provision at the hospitals, and facilitation of income generating programmes for caregivers.


Subject(s)
Appointments and Schedules , Caregivers/psychology , Disabled Children/rehabilitation , Patient Acceptance of Health Care/psychology , Adult , Child, Preschool , Cross-Sectional Studies , Female , Health Services Accessibility , Humans , Infant , Male , Social Support , Socioeconomic Factors , Surveys and Questionnaires , Time Factors , Zimbabwe
7.
Minerva Stomatol ; 63(9): 307-14, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25308568

ABSTRACT

AIM: The aim of this study was to analyze the variations in nasal dimensions in prepubertal patients associated with RME therapy compared with an untreated age matched control group. METHODS: A group of 61 subjects (26 F, 35 M; mean age 10.5±1.8 years) was enrolled in the study to undergo a rapid maxillary expansion therapy; 41 subjects (26 F, 15 M; mean age 10.7±2.2 years) were enrolled as a control group. Both groups underwent nasal soft tissues width measurements using a caliper at three separate time points: T0 - prior to the placement of RME; T1 - after completion of active expansion phase; T2 - at the removal of the expander (nearly 6 months after T1). RESULTS: The ANOVA showed statistically significant increments (P<0.0001) of the greater alar cartilage (GAC) measurement (0.8±0.2 mm) in the study group, differences for the AB measurements were not statistically significant (P=0.0784). CONCLUSION: The treatment of rapid maxillary expansion can induce an increase in GAC soft tissues width of about 1 mm in prepubertal patients. This increase could not be considered of clinical impact. The alar base width increase less than GAC, this increase is without statistical significance.


Subject(s)
Nose/anatomy & histology , Palatal Expansion Technique , Child , Female , Humans , Male , Time Factors
8.
J Clin Oncol ; 18(7): 1451-7, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10735892

ABSTRACT

PURPOSE: In our previous phase II study, the cisplatin, gemcitabine, and vinorelbine (PGV) regimen produced a median survival time (MST) of approximately 1 year in advanced non-small-cell lung cancer (NSCLC) patients. The present study was aimed at comparing the MST of patients treated with this triplet regimen with the MSTs of patients receiving cisplatin and vinorelbine (PV) or cisplatin and gemcitabine (PG). PATIENTS AND METHODS: From April 1997, patients with locally advanced or metastatic NSCLC, an age of < or = 70 years, and an Eastern Cooperative Oncology Group performance status < or = 1 were randomized to receive one of the following regimens: cisplatin 50 mg/m(2), gemcitabine 1,000 mg/m(2), and vinorelbine 25 mg/m(2) on days 1 and 8 every 3 weeks (arm A); cisplatin 100 mg/m(2) on day 1 and gemcitabine 1,000 mg/m(2) on days 1, 8, and 15 every 4 weeks (arm B); or cisplatin 120 mg/m(2) on days 1 and 29 and vinorelbine 30 mg/m(2)/wk (arm C). According to the two-stage design for phase III trials, an interim analysis was planned when the first 60 patients per arm were assessable for survival. RESULTS: The survival data of 180 NSCLC patients (stage IIIB, 76 patients; stage IV, 104 patients) were analyzed in April 1999. Overall, 128 patients had died (PGV, n = 33; PG, n = 42; and PV, n = 53). The MST of patients in the PGV, PG, and PV arms was 51, 42, and 35 weeks, respectively, and the corresponding 1-year projected survival rates were 45%, 40%, and 34%, respectively. When only patients with stage IV disease were considered, an even stronger difference was seen between PGV (MST = 47 weeks) and both PG (34 weeks) and PV (27 weeks). At multivariate Cox analysis, the estimate hazard of death for patients receiving PGV compared with those receiving PV was 0.35 (95% confidence interval, 0.16 to 0.77; P <.01). The response rates were 47% in the PGV arm, 30% in the PG arm, 25% in the PV arm. Both hematologic and nonhematologic toxicities were not substantially worse in patients who received the PGV regimen. CONCLUSION: The PGV regimen is associated with a substantial survival gain (MST > 3 months longer) when compared with the PV combination. Because this difference in survival met one of the early stopping rules, the accrual in the PV arm has been stopped (null hypothesis rejected). Enrollment still continues in the PGV and PG arm to ascertain whether the PGV regimen can also produce a significantly longer survival than that obtained with the PG regimen.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma, Non-Small-Cell Lung/drug therapy , Lung Neoplasms/drug therapy , Adult , Aged , Carcinoma, Non-Small-Cell Lung/pathology , Cisplatin/administration & dosage , Deoxycytidine/administration & dosage , Deoxycytidine/analogs & derivatives , Drug Administration Schedule , Female , Humans , Lung Neoplasms/pathology , Male , Middle Aged , Survival Analysis , Treatment Outcome , Vinblastine/administration & dosage , Vinblastine/analogs & derivatives , Vinorelbine , Gemcitabine
9.
Clin Lung Cancer ; 1(3): 202-7; discussion 208, 2000 Feb.
Article in English | MEDLINE | ID: mdl-14733645

ABSTRACT

In a previous phase II randomized study, a cisplatin/gemcitabine/vinorelbine (PGV) regimen produced a 50-week median survival time (MST) in advanced non small-cell lung cancer (NSCLC) patients. The present trial was planned to randomly compare the outcome of patients treated with this new triplet regimen with those of patients receiving either cisplatin plus vinorelbine (PV) or cisplatin plus gemcitabine (PG) doublet combinations. One hundred eighty patients with stage IIIB (76) or IV (104) disease, aged

10.
Work ; 11(3): 315-20, 1998.
Article in English | MEDLINE | ID: mdl-24441602

ABSTRACT

OBJECTIVES: The purposes of this study were first, to determine the validity of the Purdue Pegboard Test in differentiating between groups of healthy adults and adults who suffered from traumatic hand injury. Second, to determine criterion validity of the Purdue Pegboard Test with the Functional Dexterity Test (FDT). Third, to test the correlations between the Purdue Pegboard Test and several functional hand activities. STUDY DESIGNS: Fifty-four post-traumatic hand injury participants who were treated in the Occupational Therapy Clinic at the Sheba Medical Center, Tel Hashomer, Israel. Forty-three healthy participants with no history of hand injury or disease formed the control group. All subjects were assessed with the Purdue Pegboard Test, PDT and five functional hand activities. RESULTS AND CONCLUSIONS: The Purdue Pegboard Test differentiated between the healthy population and the post-traumatic hand injury population. No significant differences were found between the dominant hand-injured group and the non-dominant hand-injured group on three scores (both hands, assembly and the summarizing of the first three sub-tests). Correlations between the Purdue Pegboard Test and the PDT were moderate to high suggesting the two tests should be used in combination when assessing patients. Correlations between the Purdue and hand activities (e.g. button, laces) were moderate. Further studies are needed to examine the relationships between types of hand injuries, ROM, pinch grip and performance on the Purdue Pegboard Test.

11.
Leuk Lymphoma ; 22(5-6): 483-93, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8882962

ABSTRACT

The results of a prospective trial of an 8 week treatment for elderly patients with advanced intermediate-high grade NHL are reported. Our aim was to reduce general toxicity without losing an antilymphoma effect. For this reason the use of growth factor was studied. We also analysed the behavior of different histological groups (E + F vs G + H). From November 1991 to November 1993 100 patients older than 65 years with combination intermediate-high grade advanced stage NHL were treated with the P-VEBEC regimen, an original including epirubicin 50 mg/sqm, cyclophosphamide 300 mg/sqm and etoposide 100 mg/sqm on weeks 1, 3, 5, 7; vinblastine 5 mg/sqm and bleomycin 5 mg/sqm on weeks 2, 4, 6, 8; prednisone 50 mg/sqm/day per os in the first two weeks and thereafter every other day .46 pts received rG-CSF 5 micrograms/Kg/day throughout the treatment starting on day 2 of every week for 4 consecutive days. Twenty eight pts had B symptoms, 41 had bulky disease, 37 LDH levels above normal, 50 stage IV patients and 30 had bone marrow involvement. Sixty two percent achieved a complete remission (CR). Adverse prognostic factors for CR were E and F histology, stage IV disease, bone marrow infiltration, serum LDH levels above normal, international Prognostic Index (I.I.) intermediate-high and high risk categories and relative dose intensity (RDI) less than 0.80. Severe toxicity was rarely recorded and only one toxic death was observed. With a median follow-up of 33 months OS, DFS and EFS were 44%, 60% and 30% respectively. EFS was influenced by stage, BM involvement, level of LDH and I.I. intermediate-high and high risks. The 52 patients with DLCL (diffuse large cell lymphomas--G + H according to WF) did better with a higher CR, OS, DFS and EFS rates, than the other WF subtypes. In conclusion P-VEBEC is a feasible combination to use in elderly patients, mainly in DLCL. The use of rG-CSF improves the RDI. A RDI > 0.80 could play a role in improving the outcome, especially in patients with adverse prognostic factors. For other subgroups another schedule is probably justified.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Lymphoma, Non-Hodgkin/drug therapy , Aged , Anti-Infective Agents/therapeutic use , Antibiotic Prophylaxis , Antifungal Agents/therapeutic use , Bacterial Infections/prevention & control , Bleomycin/administration & dosage , Bone Marrow/pathology , Cyclophosphamide/administration & dosage , Disease-Free Survival , Drug Administration Schedule , Epirubicin/administration & dosage , Etoposide/administration & dosage , Feasibility Studies , Female , Granulocyte Colony-Stimulating Factor/therapeutic use , Humans , Ketoconazole/therapeutic use , Lymphoma, Non-Hodgkin/mortality , Lymphoma, Non-Hodgkin/pathology , Male , Mycoses/prevention & control , Neoplasm Staging , Ofloxacin/therapeutic use , Prednisone/administration & dosage , Prognosis , Prospective Studies , Recombinant Proteins/therapeutic use , Survival Rate , Vinblastine/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...